45.28
price up icon7.76%   3.26
after-market Handel nachbörslich: 45.28
loading
Schlusskurs vom Vortag:
$42.02
Offen:
$42.07
24-Stunden-Volumen:
1.07M
Relative Volume:
1.09
Marktkapitalisierung:
$3.71B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.72M
KGV:
-80.86
EPS:
-0.56
Netto-Cashflow:
$-103.81M
1W Leistung:
+6.09%
1M Leistung:
+16.67%
6M Leistung:
+201.87%
1J Leistung:
+157.86%
1-Tages-Spanne:
Value
$42.07
$45.98
1-Wochen-Bereich:
Value
$39.67
$45.98
52-Wochen-Spanne:
Value
$11.39
$45.98

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
Firmenname
Verona Pharma Plc Adr
Name
Telefon
011-44-0-2032834200
Name
Adresse
3 MORE LONDON RIVERSIDE, LONDON
Name
Mitarbeiter
79
Name
Twitter
@VeronaPharma
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
VRNA's Discussions on Twitter

Vergleichen Sie VRNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VRNA
Verona Pharma Plc Adr
45.28 3.71B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.27 104.37B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
715.13 78.59B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
628.32 37.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.26 31.25B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.51 27.21B 3.30B -501.07M 1.03B -2.1146

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-03 Eingeleitet Wells Fargo Overweight
2023-05-22 Fortgesetzt Jefferies Buy
2022-09-19 Fortgesetzt Wedbush Outperform
2022-08-26 Eingeleitet Piper Sandler Overweight
2021-09-13 Eingeleitet H.C. Wainwright Buy
2020-08-25 Eingeleitet Jefferies Buy
2020-08-10 Eingeleitet Canaccord Genuity Buy
2019-04-18 Eingeleitet BTIG Research Buy
Alle ansehen

Verona Pharma Plc Adr Aktie (VRNA) Neueste Nachrichten

pulisher
Dec 07, 2024

Verona Pharma CFO Mark Hahn sells shares worth $4.4 million - Investing.com India

Dec 07, 2024
pulisher
Dec 06, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $4.36 million - Investing.com

Dec 06, 2024
pulisher
Dec 02, 2024

Verona Pharma's CFO Mark Hahn sells shares worth $566,821 - Investing.com India

Dec 02, 2024
pulisher
Dec 02, 2024

Verona Pharma's CFO Mark Hahn sells shares worth $566,821 By Investing.com - Investing.com South Africa

Dec 02, 2024
pulisher
Dec 02, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $627,233 - Investing.com

Dec 02, 2024
pulisher
Nov 27, 2024

Verona Pharma CFO sells shares totaling $12,000 - Investing.com India

Nov 27, 2024
pulisher
Nov 27, 2024

Verona Pharma's chief medical officer sells $1.18 million in shares - Investing.com India

Nov 27, 2024
pulisher
Nov 26, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $8,000 - Investing.com

Nov 26, 2024
pulisher
Nov 18, 2024

Verona Pharma director David Ebsworth buys $88,800 in shares - Investing.com India

Nov 18, 2024
pulisher
Nov 07, 2024

Verona Pharma director Christina Ackermann acquires $198,385 in shares - Investing.com

Nov 07, 2024
pulisher
Nov 05, 2024

Verona Pharma CFO Mark Hahn sells shares worth $568,386 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Verona Pharma CEO David Zaccardelli sells $618,657 in shares - Investing.com

Nov 05, 2024
pulisher
Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre By Investing.com - Investing.com Nigeria

Nov 04, 2024
pulisher
Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday - Investing.com Nigeria

Nov 04, 2024
pulisher
Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa

Nov 04, 2024
pulisher
Nov 04, 2024

Verona Pharma ADR earnings matched, revenue topped estimates By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Oct 25, 2024

Verona Pharma CFO Mark Hahn sells shares worth $632,760 - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $633,895 - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma - Barchart

Oct 25, 2024
pulisher
Oct 24, 2024

5 Biotech Stocks Likely To Outperform As Industry Prospects Look Bright - Barchart

Oct 24, 2024
pulisher
Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares By Investing.com - Investing.com South Africa

Oct 22, 2024
pulisher
Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million By Investing.com - Investing.com South Africa

Oct 22, 2024
pulisher
Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million - Investing.com India

Oct 22, 2024
pulisher
Oct 21, 2024

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Yahoo Finance

Oct 21, 2024
pulisher
Oct 16, 2024

Market Insights: Verona Pharma Plc ADR (VRNA)’s Notable Drop of -0.55, Closing at 34.07 - The Dwinnex

Oct 16, 2024
pulisher
Oct 15, 2024

Verona Pharma Plc ADR [VRNA] Insider Activity: An Update for Investors - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Verona Pharma Plc ADR (VRNA) stock: A year of ups and downs - US Post News

Oct 15, 2024
pulisher
Oct 11, 2024

VRNA Shares Experience Decline in Value - Knox Daily

Oct 11, 2024
pulisher
Oct 09, 2024

Financial Metrics Exploration: Understanding Verona Pharma Plc ADR (VRNA) Through Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

A stock that deserves closer examination: Verona Pharma Plc ADR (VRNA) - US Post News

Oct 09, 2024
pulisher
Oct 09, 2024

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Wells Fargo gives an Overweight recommendation for Verona Pharma Plc ADR (VRNA) - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Verona Pharma Plc ADR’s (NASDAQ: VRNA) Stock Forecast: Increase To $38 In A Year - Stocks Register

Oct 08, 2024
pulisher
Oct 07, 2024

Prepare Yourself for Liftoff: Verona Pharma Plc ADR (VRNA) - SETE News

Oct 07, 2024
pulisher
Oct 04, 2024

Verona Pharma Plc ADR [VRNA] stock for 2,254,320 USD was sold by ZACCARDELLI DAVID - Knox Daily

Oct 04, 2024
pulisher
Oct 04, 2024

Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 04, 2024
pulisher
Oct 04, 2024

Cactus Inc [WHD] Records 50-Day SMA of $59.34 - Knox Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Verona Pharma stock soars to all-time high of $30.76 By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Piper Sandler maintains Overweight rating on Verona Pharma shares By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Sea Limited Sponsored ADR (SE) Stock Moves -0.17%: What You Should Know - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Verona Pharma stock soars to all-time high of $30.76 - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

VRNA’s Stock Market Adventure: 58.43% YTD Growth Amidst Volatility - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Moves 6.2% Higher: Will This Strength Last? - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Tesla and Nvidia Lead Afternoon Market Cap Stock Movers on Thursday - Investing.com

Oct 03, 2024
pulisher
Oct 02, 2024

MINISO Group Holding Limited Unsponsored ADR (MNSO) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Oct 02, 2024
pulisher
Oct 02, 2024

Verona Pharma Plc ADR (VRNA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Oct 02, 2024
pulisher
Oct 01, 2024

Investing in Verona Pharma Plc ADR (VRNA) might be a great opportunity, but the stock is a bit overvalued - US Post News

Oct 01, 2024

Finanzdaten der Verona Pharma Plc Adr-Aktie (VRNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$69.84
price up icon 1.45%
$18.67
price up icon 4.48%
$39.59
price up icon 0.51%
$363.65
price up icon 1.13%
$177.70
price up icon 0.68%
$113.51
price up icon 0.38%
Kapitalisierung:     |  Volumen (24h):